166 related articles for article (PubMed ID: 29731374)
1. [Inhaled chemotherapy - Part 2: Clinical practice and potential applications].
Rosière R; Hureaux J; Levet V; Amighi K; Wauthoz N
Rev Mal Respir; 2018 Apr; 35(4):378-389. PubMed ID: 29731374
[TBL] [Abstract][Full Text] [Related]
2. [Inhaled chemotherapy - Part 1: General concept and current technological challenges].
Rosière R; Hureaux J; Levet V; Amighi K; Wauthoz N
Rev Mal Respir; 2018 Apr; 35(4):357-377. PubMed ID: 29731372
[TBL] [Abstract][Full Text] [Related]
3. Inhaled cytotoxic chemotherapy: clinical challenges, recent developments, and future prospects.
Wauthoz N; Rosière R; Amighi K
Expert Opin Drug Deliv; 2021 Mar; 18(3):333-354. PubMed ID: 33050733
[TBL] [Abstract][Full Text] [Related]
4. Aerosolized chemotherapy.
Gagnadoux F; Hureaux J; Vecellio L; Urban T; Le Pape A; Valo I; Montharu J; Leblond V; Boisdron-Celle M; Lerondel S; Majoral C; Diot P; Racineux JL; Lemarie E
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):61-70. PubMed ID: 18518832
[TBL] [Abstract][Full Text] [Related]
5. Present Situation and Future Progress of Inhaled Lung Cancer Therapy: Necessity of Inhaled Formulations with Drug Delivery Functions.
Okuda T; Okamoto H
Chem Pharm Bull (Tokyo); 2020; 68(7):589-602. PubMed ID: 32611996
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.
Mangal S; Gao W; Li T; Zhou QT
Acta Pharmacol Sin; 2017 Jun; 38(6):782-797. PubMed ID: 28504252
[TBL] [Abstract][Full Text] [Related]
7. [Inhalation therapy: inhaled corticosteroids in ENT, development and technical challenges of powder inhalers, nebulisers synchronized with breathing and aerosol size distribution. GAT aerosolstorming, Paris 2012].
Le Guen P; Peron N; Durand M; Pourchez J; Cavaillon P; Reychler G; Vecellio L; Dubus JC
Rev Mal Respir; 2013 Oct; 30(8):657-68. PubMed ID: 24182652
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and safety of targeted cisplatin delivery to a select lung lobe in dogs via the AeroProbe intracorporeal nebulization catheter.
Selting K; Waldrep JC; Reinero C; Branson K; Gustafson D; Kim DY; Henry C; Owen N; Madsen R; Dhand R
J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):255-68. PubMed ID: 18759657
[TBL] [Abstract][Full Text] [Related]
9. Aerosol Delivery in the Treatment of Lung Cancer.
Storti C; Le Noci V; Sommariva M; Tagliabue E; Balsari A; Sfondrini L
Curr Cancer Drug Targets; 2015; 15(7):604-12. PubMed ID: 26033086
[TBL] [Abstract][Full Text] [Related]
10. Interest of pharmacoepidemiology for the study of inhaled drugs.
Molimard M; Girodet PO; Van Ganse E
Therapie; 2019 Apr; 74(2):233-237. PubMed ID: 30392699
[TBL] [Abstract][Full Text] [Related]
11. Inhaled chemotherapy in lung cancer: future concept of nanomedicine.
Zarogoulidis P; Chatzaki E; Porpodis K; Domvri K; Hohenforst-Schmidt W; Goldberg EP; Karamanos N; Zarogoulidis K
Int J Nanomedicine; 2012; 7():1551-72. PubMed ID: 22619512
[TBL] [Abstract][Full Text] [Related]
12. [Adaptations of the European Respiratory Society guidelines by the Aerosol Therapy Group of the French Lung Society on the use of aerosol therapy through nebulization].
Becquemin MH; Chaumuzeau JP
Rev Mal Respir; 2004 Nov; 21(5 Pt 1):889-90. PubMed ID: 15622332
[No Abstract] [Full Text] [Related]
13. Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats.
Gaspar MM; Radomska A; Gobbo OL; Bakowsky U; Radomski MW; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):310-8. PubMed ID: 22857016
[TBL] [Abstract][Full Text] [Related]
14. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
Rudokas M; Najlah M; Alhnan MA; Elhissi A
Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
[TBL] [Abstract][Full Text] [Related]
15. [Inhaled medication and inhalation devices for lung disease].
Solé A; Girón RM
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():19-24. PubMed ID: 26365729
[TBL] [Abstract][Full Text] [Related]
16. Aerosol therapy for malignancy involving the lungs.
Rao RD; Markovic SN; Anderson PM
Curr Cancer Drug Targets; 2003 Aug; 3(4):239-50. PubMed ID: 12871055
[TBL] [Abstract][Full Text] [Related]
17. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
18. Drugs by inhalatory route: an overview and upcoming clinical perspectives.
Melillo EM; Balzano G
Monaldi Arch Chest Dis; 1996 Oct; 51(5):405-12. PubMed ID: 9009629
[TBL] [Abstract][Full Text] [Related]
19. Targeting the lung: preclinical and comparative evaluation of anticancer aerosols in dogs with naturally occurring cancers.
Khanna C; Vail DM
Curr Cancer Drug Targets; 2003 Aug; 3(4):265-73. PubMed ID: 12871057
[TBL] [Abstract][Full Text] [Related]
20. How Should Aerosols Be Delivered During Invasive Mechanical Ventilation?
Dhand R
Respir Care; 2017 Oct; 62(10):1343-1367. PubMed ID: 28874611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]